EVC2 anticorps (AA 1246-1308)
-
- Antigène Voir toutes EVC2 Anticorps
- EVC2 (Ellis Van Creveld Syndrome 2 (EVC2))
-
Épitope
- AA 1246-1308
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp EVC2 est non-conjugé
-
Application
- Western Blotting (WB), Immunofluorescence (IF)
- Purification
- Purified by antigen-affinity chromatography.
- Immunogène
- Synthetic peptide contain a sequence corresponding to a region within amino acids 1246 and 1308 of EVC2
- Top Product
- Discover our top product EVC2 Anticorps primaire
-
-
- Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.100-1.250
Immunofluorescence: 1.100-1.200 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
- Agent conservateur
- Thimerosal (Merthiolate)
- Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
- Antigène
- EVC2 (Ellis Van Creveld Syndrome 2 (EVC2))
- Autre désignation
- EVC2 (EVC2 Produits)
- Synonymes
- anticorps EVC2, anticorps LBN, anticorps 1110017L09Rik, anticorps Lbn, anticorps limbin, anticorps EvC ciliary complex subunit 2, anticorps EVC2, anticorps Evc2
- Poids moléculaire
- 148 kDa
- ID gène
- 132884
- NCBI Accession
- NM_147127, NP_667338
- Pathways
- Signalisation Hedgehog
-